Who is sponsoring NCT05405920?

NCT05405920 is sponsored by Tulane University.

What drugs are being tested in NCT05405920?

Interventions in NCT05405920: Team-based Care Strategy for Hypertension Control, Enhanced Usual Care.

What condition does NCT05405920 study?

NCT05405920 studies Hypertension, Blood Pressure.

Is NCT05405920 still recruiting?

NCT05405920 is currently active, enrolled. Last updated 26 November 2024.

Last reviewed 2024-11-26 · How we verify

NCT05405920: CATCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Caribbean and South America Team-based Strategy to Control Hypertension

Active, enrolled NA Last updated 26 November 2024

What this trial tests

NA trial testing Team-based Care Strategy for Hypertension Control in Hypertension in 1,280 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 February 2023

Primary endpoint
31 August 2026

31 August 2026

Quick facts

Lead sponsor	Tulane University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,280
Start date	1 February 2023
Primary completion	31 August 2026
Estimated completion	31 August 2026
Sites	2 locations across Jamaica, Colombia

Drugs / interventions tested

Team-based Care Strategy for Hypertension Control
Enhanced Usual Care

Conditions studied

Hypertension — all drugs for Hypertension →
Blood Pressure — all drugs for Blood Pressure →

Sponsor

Tulane University

Who can join

18 and older, any sex, with Hypertension or Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The CATCH cluster randomized trial will test the implementation and effectiveness outcomes of implementing and scaling up a team-based care strategy for blood pressure control in Colombia and Jamaica.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Caribbean and South American team-based strategy to control hypertension (CATCH): Rationale and study design of a cluster randomized trial.
Mills KT, Ferguson T, Lopez-Lopez JP, Duncan J, et al · · 2026 · PMID 41419163 · DOI 10.1016/j.ahj.2025.107329
Differences in COVID-19 Vaccination and Experiences among Patients with Hypertension in Colombia and Jamaica during the COVID-19 Pandemic.
Duncan JP, Geng S, Lindsay C, Ferguson TS, et al · · 2024 · PMID 39457329 · DOI 10.3390/ijerph21101356

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Tulane University trials

Trials by the same sponsor.

NCT04007276 — The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients · Phase 4 · not yet recruiting
NCT07062406 — Enhancing Diabetes Care by Treating Insomnia · NA · not yet recruiting
NCT06810739 — The Women's Screening and Self-Testing Program (PROMETA) Study · NA · not yet recruiting
NCT05197998 — Promoting ColorBRAVE Conversations in Families · NA · suspended
NCT06261840 — Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05405920 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tulane University
Last refreshed: 26 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05405920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing